Pharmacovigilance Market to grow at 10% CAGR from 2017 to 2024

1
Pharmacovigilance Market Analysis, Industry
Trends, Research Report 2024 Global Market
Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Pharmacovigilance Market

• Increasing adverse drug reactions across the
  globe will fuel need for pharmacovigilance
  services escalating pharmacovigilance market
  growth over forecast timeframe.
• Adverse drug reactions are among the common
  causes of death and morbidity within hospital
  settings.
• Pharmacovigilance Market size is set to exceed
  USD 8 billion by 2024 according to a new
  research report by Global Market Insights.
• Personalized medicine industry has witnessed
  rapid growth due to increased usage and
  acceptance in the field of cancer therapeutics.
• Regulatory authorities relentless efforts to
  bring harmonization in pharmacovigilance
  practices will impact the industry growth.
• Phase III trial is estimated to grow at highest
  CAGR from 2017 to 2024 as compared to other
  clinical trial segments.

3
Continued...

• Phase IV trial segment dominated
  pharmacovigilance market and trend is likely to
  continue in forthcoming years due to rising
  awareness and favorable regulations pertaining to
  post marketing surveillance.
• However, state of art infrastructure and skilled
  staff required for in house pharmacovigilance is
  difficult to maintain and comes with the
  additional operational cost.
• Japan dominated Asia Pacific pharmacovigilance
  market due to robust adverse drug reaction
  reporting system and healthcare infrastructure.
• India has well established presence of many
  industry players including TCS, Cognizant and
  more.
• Some of the key industry players operating in
  global Pharmacovigilance market are Accenture,
  Boehringer Ingelheim, Bristol-Myers Squibb,
  Cognizant Technology Solutions Corporation, F.
  Hoffmann-La Roche, GlaxoSmithKline, IQVIA
  (QuintilesIMS), IBM Corporation, Infosys, Janssen
  Research Development, Ipca Laboratories,
  ITclinical, Laboratory Corporation of America
  Holdings, Novartis AG, Pfizer, Sanofi Aventis,
  TCS, and Wipro.

4
India Pharmacovigilance Market, By Clinical Trial
Phase, 2012 - 2024

5

Browse Full Market Research Report On
Pharmacovigilance Market _at_https//bit.ly/2i8RiRE
Request for a Sample of this Research Report
_at_ https//www.gminsights.com/request-sample/detail
/853 https//www.gminsights.com/request-sample/de
tail/49
6
Stay In Touch Website www.gminsights.com Soci
al Media